Aortic valve stenosis is the most common valvular heart disease requiring treatment in Europe. Transcatheter aortic valve implantation (TAVI) has already been established as a standard therapy in patients with high but also intermediate risk.In the meantime, it is even being performed more frequently than surgical replacement in Germany.This article presents current data, indications and future challenges.
© Georg Thieme Verlag KG Stuttgart · New York.